Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-23.21
Price to sales ratio

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2498
LXRX
Lexicon Pharmaceuticals, Inc. - Common Stock
2.17 USD-2.25%-6.47%+11.28%+82.35%963.91 M USD
2506
SLDB
Solid Biosciences Inc. - Common Stock
9.72 USD-6.72%-12.20%+33.70%+70.53%956.93 M USD
2524
LBRX
LB Pharmaceuticals Inc - Common Stock
32.25 USD-2.12%-6.03%+12.96%+69.74%924.82 M USD
2525
ABUS
Arbutus Biopharma Corporation - Common Stock
4.67 USD-2.71%-6.22%+8.60%+44.58%922.50 M USD

Frequently asked questions about DBV Technologies S.A. - American Depositary Shares

What is the DBV Technologies S.A. - American Depositary Shares stock price today?

The current price of DBV Technologies S.A. - American Depositary Shares (DBVT) is 15.98. Over the past 24 hours, the stock has changed by -3.09%. Follow the DBVT chart for real-time price dynamics.

What is the stock ticker of DBV Technologies S.A. - American Depositary Shares?

DBV Technologies S.A. - American Depositary Shares trades under the ticker DBVT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is DBV Technologies S.A. - American Depositary Shares stock going up?

DBVT has changed by -0.44% over the last week, -9.62% over the last month, and +53.21% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was DBV Technologies S.A. - American Depositary Shares net income for the last quarter?

DBV Technologies S.A. - American Depositary Shares reported net income of -47.6 M for the last quarter. The previous quarter showed -44.81 M, which means net income changed by -6.23%.

How many employees does DBV Technologies S.A. - American Depositary Shares have?

As of the latest available data, DBV Technologies S.A. - American Depositary Shares has 161 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy DBV Technologies S.A. - American Depositary Shares stock?

You can buy DBV Technologies S.A. - American Depositary Shares (DBVT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in DBV Technologies S.A. - American Depositary Shares stock?

Investing in DBV Technologies S.A. - American Depositary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the DBVT chart and related analysis on metatrader.com as part of your research.

DBV Technologies S.A. - American Depositary Shares

DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.

News